| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | Consumer Defensive | UBS | Maintains | Buy → Buy | — | $1.1T | $51.90 | -0.3% | +1.4% | -0.3% | -0.3% | +0.7% | -0.8% |
| ROST | Consumer Cyclical | UBS | Maintains | Sell → Sell | — | $68.7B | $113.06 | +3.0% | +5.0% | +0.4% | -1.1% | +3.5% | -2.5% |
| LITE | Technology | UBS | Maintains | Neutral → Neutral | — | $62.0B | $46.20 | -1.5% | +3.9% | +1.4% | +5.4% | +3.6% | -2.0% |
| BILI | Technology | UBS | Maintains | Buy → Buy | — | $8.1B | $15.35 | -5.3% | -6.4% | +2.6% | -0.9% | +1.7% | +0.5% |
| NCLH | Consumer Cyclical | UBS | Maintains | Neutral → Neutral | — | $6.8B | $16.78 | -1.6% | -0.6% | +2.0% | +1.5% | +1.8% | -3.6% |
| BILL | Technology | UBS | Maintains | Buy → Buy | — | $4.0B | $101.56 | -6.9% | +9.3% | -3.1% | +1.0% | +0.9% | -4.1% |
| PRVA | Healthcare | UBS | Maintains | Buy → Buy | — | $3.0B | $25.10 | -1.6% | +0.2% | -0.2% | -1.3% | +1.9% | -2.3% |